Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial.

Journal of affective disorders - 1 Jan 2014

Sharpley Ann L, Hockney Rena, McPeake Lily, Geddes John R, Cowen Philip J

Abstract excerpt

BACKGROUND: Clinical mood disorders often become clinically manifest in the later teenage years and early twenties and can be associated with a poor long-term prognosis. The primary prevention of these disorders would therefore have great public health value. Nutritional supplements are a feasible intervention for primary prevention and several epidemiological studies have indicated links between low folate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnostic and Statistical Manual of Mental Disorders

Share to Dietary Supplements

Share to Double-Blind Method

Share to Folic Acid

Share to Incidence

Source

Identifiers

PMID: 25010374
DOI: 10.1016/j.jad.2014.06.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial.PMID 25010374Read ↗

Folic acid supplementation during pregnancy may protect against depression 21 months after pregnancy, an effect modified by MTHFR C677T genotype.Semantic proximity Read ↗

Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders.Semantic proximity Read ↗

Folate and long-chain polyunsaturated fatty acids in psychiatric diseaseSemantic proximity Read ↗

Folate metabolism genes, dietary folate and response to antidepressant medications in late-life depression.Semantic proximity Read ↗

Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disordersSemantic proximity Read ↗

Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders.Semantic proximity Read ↗

Folinic Acid Treatment of Parents Positive for Folate Receptor Autoantibodies Could Reduce the Risk of Autism in Their OffspringSemantic proximity Read ↗

The folic acid endophenotype and depression in an elderly population.Semantic proximity Read ↗

Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA)Semantic proximity Read ↗

Omega 3 polyunsaturated fatty acids and the treatment of depression.Semantic proximity Read ↗

Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study.Semantic proximity Read ↗

Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.